Total raised
—
Last: Undisclosed 2025-04
Stage
Seed
Founded
2021
Headcount
11
HQ
Hod HaSharon
Sector
Health Tech & Life Sciences
About
HTVET develops an ai-driven solution for early diagnosis of cancer and save pets’ lives, and to empower clinicians to rule out cancer quickly and confidently. HT Vista device is the first AI-driven non-invasive screening tool that allows vets & nurses to rule out cancer of dermal & subcutaneous masses in dogs. By using the company's unique Heat Diffusion Imaging (HDI) technology & cloud-based analysis, vets & nurses are able to rule out cancer on-the-spot and in their own practice.
HT Vet LTD is a subsidiary of HT Bioimaging, an Israeli-based company.
Funding history · 1 round · — total
2025-04
Undisclosed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is HT Vet's primary focus?
- HT Vet develops an AI-driven non-invasive screening tool called HT Vista for the early diagnosis and rule-out of cancer in dermal and subcutaneous masses in dogs.
- When was HT Vet founded?
- HT Vet was founded in January 2021.
- What technology does HT Vet utilize for its cancer screening tool?
- HT Vet uses its unique Heat Diffusion Imaging (HDI) technology combined with cloud-based analysis for its HT Vista device.
- What is the current employee count for HT Vet?
- HT Vet currently has between 11 and 50 employees.
- Who are the founders of HT Vet?
- The founders of HT Vet are Gideon Barak and Shani Toledano.
- What is HT Vet's relationship with HT Bioimaging?
- HT Vet LTD is a subsidiary of HT Bioimaging, an Israeli-based company.
- Has HT Vet secured any funding rounds?
- In April 2025, HT Vet secured an undisclosed funding round with NextLeap Ventures as an investor. For full financing history, users should refer to startupim.
- What is the product name offered by HT Vet?
- HT Vet offers a product named HT Vista.
- What new cancer diagnostic service did HT Vet's Vista IQ introduce?
- In January 2026, HT Vet's Vista IQ introduced a new cancer diagnostic service, which is projected to unlock $130,000 in annual revenue for veterinary clinics.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Technologies
Artificial IntelligenceSimulation & Imaging
Target customers
ConsumersRecreational & LifestylePet OwnersHealthcare & Life Sciences
Business model
B2B2CB2B
Highlights
1 PatentsVerified
Tags
dogsdiagnosticspetsveterinarycancer-diagnostics